TipRanks
Advertisement
Advertisement
Standard BioTools to sell Mass Cytometry business to Multiplex Bio for $10M
PremiumThe FlyStandard BioTools to sell Mass Cytometry business to Multiplex Bio for $10M
2M ago
Standard BioTools Receives Nasdaq Bid Price Deficiency Notice
Premium
Company Announcements
Standard BioTools Receives Nasdaq Bid Price Deficiency Notice
2M ago
Standard BioTools files registration statement for Treeline Biosciences merger
Premium
The Fly
Standard BioTools files registration statement for Treeline Biosciences merger
2M ago
Standard BioTools Regains Nasdaq Minimum Bid Compliance Status
PremiumCompany AnnouncementsStandard BioTools Regains Nasdaq Minimum Bid Compliance Status
4M ago
Standard BioTools Grants RSUs to Chief Business Officer
Premium
Company Announcements
Standard BioTools Grants RSUs to Chief Business Officer
4M ago
Standard BioTools Adopts New Executive Severance Protection Plans
Premium
Company Announcements
Standard BioTools Adopts New Executive Severance Protection Plans
4M ago
Standard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
PremiumRatingsStandard BioTools: Neutral Stance Amid Revenue Contraction Risk and M&A-Dependent Growth Outlook
7M ago
Standard BioTools Details SomaLogic Sale and Profitability Path
Premium
Company Announcements
Standard BioTools Details SomaLogic Sale and Profitability Path
7M ago
Standard BioTools reports Q4 EPS 5c vs (9c) last year
Premium
The Fly
Standard BioTools reports Q4 EPS 5c vs (9c) last year
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―